VivoSim Labs, INC.
VivoSim Labs, INC. (VIVS): 1 pipeline candidate · ~6 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
6.4 months
D/E 0.57 · 0% dilution
Lead: Phase 2
1 candidate
N/A
N/A
A transparent, data-derived signal for VivoSim Labs, INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$3.4M
Cash
$4.3M
Quarterly Burn
$2.3M
Runway
6.4 mo
Revenue
$26K
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (1 candidate)
| Drug | Phase |
|---|---|
| fxr314 | Phase 2 |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
20
Total value held
$157K
| Holder | Shares | Value |
|---|---|---|
| geode capital management, llc | 36,850 | $53K |
| vanguard capital management llc | 30,742 | $44K |
| goldman sachs group inc | 16,072 | $23K |
| blackrock, inc. | 11,817 | $17K |
| vanguard fiduciary trust co | 7,003 | $10K |
| citigroup inc | 6,504 | $9K |
| larson financial group llc | 166 | $237 |
| albion financial group /ut | 159 | $228 |
| wells fargo & company/mn | 111 | $158 |
| osaic holdings, inc. | 95 | $131 |
Showing top 10 of 20 institutional holders of VivoSim Labs, INC.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in VivoSim Labs, INC.'s pipeline?
VivoSim Labs, INC. (VIVS) has 1 pipeline candidate tracked by BioSniper across SEC filings and clinical trial registrations.
What is VivoSim Labs, INC.'s lead drug candidate?
VivoSim Labs, INC.'s most advanced tracked candidate is fxr314 (Phase 2) for Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease (CD); metabolic function-associated steatohepatitis (MASH).
What is VivoSim Labs, INC.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, VivoSim Labs, INC. has approximately 6.4 months of cash runway.
What is VivoSim Labs, INC.'s market capitalization?
VivoSim Labs, INC.'s market capitalization is approximately $3.4M.
Who is the CEO of VivoSim Labs, INC.?
Douglas Jay Cohen is the chief executive officer of VivoSim Labs, INC. (VIVS).
Get the full picture on VivoSim Labs, INC.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.